FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

19499001: Carbinoxamine maleate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
32845012 Carbinoxamine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
747687013 Carbinoxamine maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
24251000188116 carbinoxamine maléate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
797741000172110 maléate de carbinoxamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbinoxamine maleate Is a Product containing carbinoxamine (medicinal product) false Inferred relationship Some
Carbinoxamine maleate Is a Carbinoxamine (substance) false Inferred relationship Some
Carbinoxamine maleate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine receptor antagonist (disposition) true Inferred relationship Some
Carbinoxamine maleate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Carbinoxamine (substance) true Inferred relationship Some
Carbinoxamine maleate Is a Ethanolamine derivative antihistamine true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbinoxamine maleate 2mg/5mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+pseudoephedrine hydrochloride 4mg/5mL/60mg/5mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/25mg/1mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/5mL/30mg/5mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Product containing carbinoxamine maleate and pseudoephedrine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Carbinoxamine maleate Inferred relationship Some 1
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbinoxamine maleate Inferred relationship Some
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Carbinoxamine maleate Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 2
Carbinoxamine maleate 4 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carbinoxamine maleate Inferred relationship Some 1
Carbinoxamine maleate 4 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carbinoxamine maleate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start